Market Overview

BioXcel Therapeutics (NASDAQ: BTAI)

44.59 -0.06 (-0.13%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/18/20Canaccord GenuityMaintainsBuy110.0
9/02/20JefferiesInitiates Coverage OnBuy82.0
8/17/20BMO CapitalMaintainsOutperform95.0
8/17/20HC Wainwright & Co.MaintainsBuy175.0
7/21/20Canaccord GenuityMaintainsBuy120.0
7/20/20HC Wainwright & Co.MaintainsBuy200.0
7/13/20B of A SecuritiesReiteratesBuy63.0
7/08/20HC Wainwright & Co.ReiteratesBuy120.0
6/04/20GuggenheimInitiates Coverage OnBuy101.0
4/01/20B of A SecuritiesInitiates Coverage OnBuy45.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter